US Stock MarketDetailed Quotes

NKGen Biotech (NKGN)

Watchlist
  • 0.0600
  • 0.00000.00%
15min DelayTrading Jan 22 13:59 ET
2.72MMarket Cap-0.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NKGen Biotech (NKGN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.59%-2.8M
4.86%-20.88M
-0.20%-6.95M
14.68%-3.9M
-8.48%-6M
17.91%-4.03M
2.70%-21.95M
-26.95%-6.94M
-4.57M
-5.53M
Net income from continuing operations
385.21%15.35M
46.61%-44.29M
12.47%-29.41M
119.89%6.6M
-104.97%-16.09M
35.33%-5.38M
-210.06%-82.95M
-383.68%-33.61M
---33.18M
---7.85M
Operating gains losses
----
22.88%30.62M
1,889.37%8.79M
--16.88M
--5.22M
---275K
--24.92M
--442K
----
----
Depreciation and amortization
16.26%379K
9.31%1.32M
10.33%331K
10.67%332K
9.03%326K
7.24%326K
-0.58%1.2M
-1.96%300K
--300K
--299K
Deferred tax
----
--53K
----
----
----
----
--0
----
----
----
Other non cash items
-13.41%1.45M
-52.92%1.98M
-35.84%188K
-91.92%293K
86.41%-184K
2.94%1.68M
54.74%4.2M
-59.14%293K
--3.63M
---1.35M
Change In working capital
-61.05%886K
-38.27%1.37M
-288.50%-2.67M
67.21%1.65M
131.38%123K
953.24%2.28M
7,320.00%2.23M
299.15%1.42M
--985K
---392K
-Change in receivables
----
--0
--0
--0
--0
--0
200.00%29K
--0
--0
--0
-Change in prepaid assets
-138.79%-128K
56.95%-604K
-317.76%-1.53M
126.05%193K
352.83%402K
340.88%330K
-2,561.40%-1.4M
-451.92%-366K
---741K
---159K
-Change in payables and accrued expense
-41.77%1.08M
-43.33%2.26M
-138.46%-728K
-20.59%1.43M
-112.32%-293K
325.00%1.85M
801.35%3.99M
437.78%1.89M
--1.8M
---138K
-Change in other current liabilities
-169.89%-65K
24.80%-285K
-331.25%-414K
124.73%23K
114.29%13K
193.94%93K
13.27%-379K
12.73%-96K
---93K
---91K
-Change in other working capital
----
----
----
----
----
92.31%-1K
-250.00%-14K
----
----
---4K
Cash from discontinued investing activities
Operating cash flow
30.59%-2.8M
4.86%-20.88M
-0.20%-6.95M
14.68%-3.9M
-8.48%-6M
17.91%-4.03M
2.70%-21.95M
-26.95%-6.94M
---4.57M
---5.53M
Investing cash flow
Cash flow from continuing investing activities
-248.57%-52K
72.92%-13K
11.11%-16K
-17K
11.76%-15K
369.23%35K
70.55%-48K
-260.00%-18K
0
-17K
Capital expenditure reported
---52K
0.00%-48K
11.11%-16K
---17K
11.76%-15K
--0
22.58%-48K
-38.46%-18K
--0
---17K
Net PPE purchase and sale
--0
--35K
--0
--0
--0
--35K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-248.57%-52K
72.92%-13K
11.11%-16K
---17K
11.76%-15K
369.23%35K
70.55%-48K
-260.00%-18K
--0
---17K
Financing cash flow
Cash flow from continuing financing activities
-33.97%2.65M
-5.88%20.85M
486.41%6.97M
-68.51%3.82M
-3.38%6.06M
-27.91%4.01M
-1.47%22.16M
-132.78%-1.8M
12.13M
6.27M
Net issuance payments of debt
-39.62%890K
-45.23%14.35M
1,707.08%3.86M
-80.23%2.53M
-19.85%6.49M
-73.46%1.47M
17.38%26.21M
-104.36%-240K
--12.79M
--8.1M
Net common stock issuance
--1.75M
144.66%4.08M
310,800.00%3.11M
-94.06%99K
--873K
--0
--1.67M
--1K
--1.67M
----
Proceeds from stock option exercised by employees
-95.60%11K
-97.55%250K
--0
--0
--0
6,150.00%250K
6,249.07%10.22M
--0
--10.21M
--8K
Net other financing activities
----
113.61%2.17M
100.06%1K
109.52%1.19M
---1.31M
--2.28M
---15.94M
---1.56M
---12.54M
----
Cash from discontinued financing activities
Financing cash flow
-33.97%2.65M
-5.88%20.85M
486.41%6.97M
-68.51%3.82M
-3.38%6.06M
-27.91%4.01M
-1.47%22.16M
-132.78%-1.8M
--12.13M
--6.27M
Net cash flow
Beginning cash position
-14.86%235K
135.90%276K
-97.38%237K
-77.65%329K
-62.03%284K
135.90%276K
-66.67%117K
10,286.21%9.04M
--1.47M
--748K
Current changes in cash
-2,675.00%-206K
-125.79%-41K
99.98%-2K
-101.22%-92K
-93.78%45K
-98.73%8K
167.95%159K
-29,300.00%-8.76M
--7.56M
--724K
End cash Position
-89.79%29K
-14.86%235K
-14.86%235K
-97.38%237K
-77.65%329K
-62.03%284K
135.90%276K
135.90%276K
--9.04M
--1.47M
Free cash flow
29.30%-2.85M
4.85%-20.93M
-0.17%-6.97M
14.30%-3.91M
-8.42%-6.01M
18.12%-4.03M
3.19%-22M
-27.16%-6.96M
---4.57M
---5.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.59%-2.8M4.86%-20.88M-0.20%-6.95M14.68%-3.9M-8.48%-6M17.91%-4.03M2.70%-21.95M-26.95%-6.94M-4.57M-5.53M
Net income from continuing operations 385.21%15.35M46.61%-44.29M12.47%-29.41M119.89%6.6M-104.97%-16.09M35.33%-5.38M-210.06%-82.95M-383.68%-33.61M---33.18M---7.85M
Operating gains losses ----22.88%30.62M1,889.37%8.79M--16.88M--5.22M---275K--24.92M--442K--------
Depreciation and amortization 16.26%379K9.31%1.32M10.33%331K10.67%332K9.03%326K7.24%326K-0.58%1.2M-1.96%300K--300K--299K
Deferred tax ------53K------------------0------------
Other non cash items -13.41%1.45M-52.92%1.98M-35.84%188K-91.92%293K86.41%-184K2.94%1.68M54.74%4.2M-59.14%293K--3.63M---1.35M
Change In working capital -61.05%886K-38.27%1.37M-288.50%-2.67M67.21%1.65M131.38%123K953.24%2.28M7,320.00%2.23M299.15%1.42M--985K---392K
-Change in receivables ------0--0--0--0--0200.00%29K--0--0--0
-Change in prepaid assets -138.79%-128K56.95%-604K-317.76%-1.53M126.05%193K352.83%402K340.88%330K-2,561.40%-1.4M-451.92%-366K---741K---159K
-Change in payables and accrued expense -41.77%1.08M-43.33%2.26M-138.46%-728K-20.59%1.43M-112.32%-293K325.00%1.85M801.35%3.99M437.78%1.89M--1.8M---138K
-Change in other current liabilities -169.89%-65K24.80%-285K-331.25%-414K124.73%23K114.29%13K193.94%93K13.27%-379K12.73%-96K---93K---91K
-Change in other working capital --------------------92.31%-1K-250.00%-14K-----------4K
Cash from discontinued investing activities
Operating cash flow 30.59%-2.8M4.86%-20.88M-0.20%-6.95M14.68%-3.9M-8.48%-6M17.91%-4.03M2.70%-21.95M-26.95%-6.94M---4.57M---5.53M
Investing cash flow
Cash flow from continuing investing activities -248.57%-52K72.92%-13K11.11%-16K-17K11.76%-15K369.23%35K70.55%-48K-260.00%-18K0-17K
Capital expenditure reported ---52K0.00%-48K11.11%-16K---17K11.76%-15K--022.58%-48K-38.46%-18K--0---17K
Net PPE purchase and sale --0--35K--0--0--0--35K--0--0--0--0
Cash from discontinued investing activities
Investing cash flow -248.57%-52K72.92%-13K11.11%-16K---17K11.76%-15K369.23%35K70.55%-48K-260.00%-18K--0---17K
Financing cash flow
Cash flow from continuing financing activities -33.97%2.65M-5.88%20.85M486.41%6.97M-68.51%3.82M-3.38%6.06M-27.91%4.01M-1.47%22.16M-132.78%-1.8M12.13M6.27M
Net issuance payments of debt -39.62%890K-45.23%14.35M1,707.08%3.86M-80.23%2.53M-19.85%6.49M-73.46%1.47M17.38%26.21M-104.36%-240K--12.79M--8.1M
Net common stock issuance --1.75M144.66%4.08M310,800.00%3.11M-94.06%99K--873K--0--1.67M--1K--1.67M----
Proceeds from stock option exercised by employees -95.60%11K-97.55%250K--0--0--06,150.00%250K6,249.07%10.22M--0--10.21M--8K
Net other financing activities ----113.61%2.17M100.06%1K109.52%1.19M---1.31M--2.28M---15.94M---1.56M---12.54M----
Cash from discontinued financing activities
Financing cash flow -33.97%2.65M-5.88%20.85M486.41%6.97M-68.51%3.82M-3.38%6.06M-27.91%4.01M-1.47%22.16M-132.78%-1.8M--12.13M--6.27M
Net cash flow
Beginning cash position -14.86%235K135.90%276K-97.38%237K-77.65%329K-62.03%284K135.90%276K-66.67%117K10,286.21%9.04M--1.47M--748K
Current changes in cash -2,675.00%-206K-125.79%-41K99.98%-2K-101.22%-92K-93.78%45K-98.73%8K167.95%159K-29,300.00%-8.76M--7.56M--724K
End cash Position -89.79%29K-14.86%235K-14.86%235K-97.38%237K-77.65%329K-62.03%284K135.90%276K135.90%276K--9.04M--1.47M
Free cash flow 29.30%-2.85M4.85%-20.93M-0.17%-6.97M14.30%-3.91M-8.42%-6.01M18.12%-4.03M3.19%-22M-27.16%-6.96M---4.57M---5.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.90%
Sample Name
Sample Code
 +3.58%
Sample Name
Sample Code
 +2.95%
4
Amazon
AMZN
+2.44%
5
NVIDIA
NVDA
+1.57%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.27%
Sample Name
Sample Code
 +9.02%
Sample Name
Sample Code
 +4.73%
4
KE Holdings
BEKE
+4.39%
5
H World Group
HTHT
+3.81%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -